Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5alpha-Androstane-3b,17b-diol, also known as 5α-Androstane-3β,17β-diol, is an androstane-3,17-diol that is 5alpha-androstane substituted by beta-hydroxy groups at positions 3 and 17. It is a metabolite of dihydrotestosterone and is derived from the metabolism of testosterone.

571-20-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 571-20-0 Structure
  • Basic information

    1. Product Name: 5alpha-Androstane-3b,17b-diol
    2. Synonyms: 3b,17b-dihydroxy-5a-androstane;3BETA,17BETA-DIHYDROXY-5ALPHA-ANDROSTANE;5ALPHA-ANDROSTAN-3BETA,17BETA-DIOL;5 ALFA-ANDROSTANE-3BETA, 17BETA-DIOL;5ALPHA-ANDROSTANE-3BETA,17BETA-DIOL;5A-ANDROSTEN-3B,17B-DIOL;5A-ANDROSTEN-3BETA,17BETA-DIOL;5A-ANDROSTAN-3B,17B-DIOL
    3. CAS NO:571-20-0
    4. Molecular Formula: C19H32O2
    5. Molecular Weight: 292.46
    6. EINECS: 209-334-3
    7. Product Categories: Steroids;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals
    8. Mol File: 571-20-0.mol
  • Chemical Properties

    1. Melting Point: 161 °C
    2. Boiling Point: 374.38°C (rough estimate)
    3. Flash Point: 186°C
    4. Appearance: /
    5. Density: 1.0164 (rough estimate)
    6. Vapor Pressure: 1.27E-08mmHg at 25°C
    7. Refractive Index: 1.4709 (estimate)
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 15.07±0.70(Predicted)
    11. CAS DataBase Reference: 5alpha-Androstane-3b,17b-diol(CAS DataBase Reference)
    12. NIST Chemistry Reference: 5alpha-Androstane-3b,17b-diol(571-20-0)
    13. EPA Substance Registry System: 5alpha-Androstane-3b,17b-diol(571-20-0)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/38
    3. Safety Statements: 24-45
    4. WGK Germany:
    5. RTECS: BV8044320
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 571-20-0(Hazardous Substances Data)

571-20-0 Usage

Uses

Used in Pharmaceutical Industry:
5alpha-Androstane-3b,17b-diol is used as an intermediate in the synthesis of various steroidal drugs for the treatment of hormonal imbalances and other related conditions. Its role as a metabolite of dihydrotestosterone makes it a valuable compound in the development of medications targeting androgen receptors.
Used in Research and Development:
5alpha-Androstane-3b,17b-diol is utilized as a research compound in the study of steroid metabolism, hormone regulation, and the development of new therapies for conditions related to androgen levels. Its presence as a metabolite of testosterone and dihydrotestosterone allows researchers to better understand the complex interactions within the endocrine system.
Used in Sports Medicine:
5alpha-Androstane-3b,17b-diol may be used as a marker in the detection of performance-enhancing drug use in sports. As a metabolite of testosterone, it can be monitored to ensure compliance with anti-doping regulations and to maintain fair competition among athletes.
Used in Endocrinology:
5alpha-Androstane-3b,17b-diol is used as a diagnostic tool in endocrinology to assess the levels of androgens in the body. This can help in the diagnosis and management of conditions such as polycystic ovary syndrome (PCOS), adrenal disorders, and other hormonal imbalances.

Check Digit Verification of cas no

The CAS Registry Mumber 571-20-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,7 and 1 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 571-20:
(5*5)+(4*7)+(3*1)+(2*2)+(1*0)=60
60 % 10 = 0
So 571-20-0 is a valid CAS Registry Number.
InChI:InChI=1/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17-,18-,19-/m0/s1

571-20-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5α-androstane-3β,17β-diol

1.2 Other means of identification

Product number -
Other names 5alpha-androstane-3beta,17beta-diol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:571-20-0 SDS

571-20-0Synthetic route

3β-acetoxy-5α-androstan-17-one
1239-31-2

3β-acetoxy-5α-androstan-17-one

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With diisobutylaluminium hydride; nickel dichloride In dichloromethane; toluene at -78℃; for 0.25h; Inert atmosphere;99%
Multi-step reaction with 2 steps
1: 97 percent / NaBH4 / methanol / 1 h / 0 - 20 °C
2: 95 percent / NaOH / methanol / 0.17 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: sodium tetrahydroborate; methanol / 0.42 h / 20 °C / Inert atmosphere
2: potassium carbonate / methanol / 24 h / 20 °C / Inert atmosphere
View Scheme
Epiandrosterone
481-29-8

Epiandrosterone

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 20℃;95%
With ethanol; nickel Hydrogenation;
With hydrogenchloride; acetic acid; platinum Hydrogenation.;
(3S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
3090-70-8

(3S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With sodium hydroxide In methanol for 0.166667h; Heating;95%
With potassium carbonate In methanol at 20℃; for 24h; Inert atmosphere;89%
With sodium hydroxide In methanol Yield given;
3β-acetoxy-5α-androstan-17-one
1239-31-2

3β-acetoxy-5α-androstan-17-one

A

(3S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
3090-70-8

(3S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

B

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With sodium tetrahydroborate In 1,4-dioxane; methanol for 6h; Ambient temperature; Yields of byproduct given;A 86%
B n/a
With sodium tetrahydroborate In 1,4-dioxane; methanol for 6h; Ambient temperature; Yields of byproduct given;A n/a
B 760 mg
3α-hydroxyandrost-4-en-17β-yl acetate
16992-89-5

3α-hydroxyandrost-4-en-17β-yl acetate

A

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

B

androstanediol
1852-53-5

androstanediol

C

17β-ethoxy-5β-androstane-3α,4β-diol

17β-ethoxy-5β-androstane-3α,4β-diol

D

5β-androstane-3α,4β,17β-triol

5β-androstane-3α,4β,17β-triol

Conditions
ConditionsYield
With sodium hydroxide; dihydrogen peroxide; diborane Product distribution; multistep reaction: 1.) THF, 0 deg C, 4 h, 2.) overnight; hydroboration of androst-4-enes; stereochemical aspects;A n/a
B n/a
C 21%
D 63%
With sodium hydroxide; dihydrogen peroxide; diborane 1.) THF, 0 deg C, 4 h, 2.) overnight; Yield given. Multistep reaction. Yields of byproduct given. Title compound not separated from byproducts;
With sodium hydroxide; dihydrogen peroxide; diborane 1.) THF, 0 deg C, 4 h, 2.) overnight; Yield given. Multistep reaction. Yields of byproduct given;
androstanedione
846-46-8

androstanedione

A

Epiandrosterone
481-29-8

Epiandrosterone

B

cis-androsterone
53-41-8

cis-androsterone

C

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
for 504h; Rhodotorula mucilaginosa;A 18%
B 35%
C 30%
Stanolone
521-18-6

Stanolone

A

Epiandrosterone
481-29-8

Epiandrosterone

B

cis-androsterone
53-41-8

cis-androsterone

C

androstanedione
846-46-8

androstanedione

D

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
for 504h; Rhodotorula mucilaginosa;A 21%
B 33%
C 5%
D 33%
Stanolone
521-18-6

Stanolone

A

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

B

5α-androstane-3β,17β,16β-triol
27261-27-4

5α-androstane-3β,17β,16β-triol

C

5α-androstane-2β,3α,16α,17β-tetrol
121209-70-9

5α-androstane-2β,3α,16α,17β-tetrol

Conditions
ConditionsYield
With fungus Gnomonia fructicola In ethanol at 24 - 26℃; for 120h;A 3%
B 20%
C 3%
With fungus Gnomonia fructicola In ethanol at 24 - 26℃; for 120h;A 3%
B 20%
C 3%
androstanedione
846-46-8

androstanedione

A

Epiandrosterone
481-29-8

Epiandrosterone

B

11α-hydroxy-5α-androstane-3,17-dione
29907-31-1

11α-hydroxy-5α-androstane-3,17-dione

C

3β,5α-dihydroxy-5α-androstan-17-one
17752-36-2

3β,5α-dihydroxy-5α-androstan-17-one

D

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 168h;A 9%
B 3.5%
C 1%
D 5.5%
propan-1-ol
71-23-8

propan-1-ol

Epiandrosterone
481-29-8

Epiandrosterone

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With sodium
Perbenzoic acid
93-59-4

Perbenzoic acid

pregnenolone acetate
906-83-2

pregnenolone acetate

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With chloroform Kochen des Reaktionsprodukts mit wss.-methanol. KOH;
diethyl ether
60-29-7

diethyl ether

Epiandrosterone
481-29-8

Epiandrosterone

propylmagnesium iodide
10557-57-0

propylmagnesium iodide

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

diethyl ether
60-29-7

diethyl ether

3β-acetoxy-5α-androstan-17-one
1239-31-2

3β-acetoxy-5α-androstan-17-one

isopropylmagnesium iodide
1068-56-0

isopropylmagnesium iodide

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
Versetzen mit wss.HCl und Erwaermen des Reaktionsprodukts mit methanol.KOH;
ethanol
64-17-5

ethanol

1-testosterone
65-06-5

1-testosterone

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
Behandeln mit gaerender Hefe;
testosterone
58-22-0

testosterone

A

Stanolone
521-18-6

Stanolone

B

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With diethyl ether; palladium Hydrogenation;
testosterone
58-22-0

testosterone

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With rot causing bacteria
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With acetic acid; platinum Hydrogenation;
With sodium tetrahydroborate; cerium(III) chloride heptahydrate In methanol Luche Cerium Reduction;
androstanedione
846-46-8

androstanedione

A

Epiandrosterone
481-29-8

Epiandrosterone

B

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
bei der Einwirkung von Faeulnisbakterien;
androstanedione
846-46-8

androstanedione

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With rot causing bacteria in a(n) aqueous yeast-suspension at 36 - 37℃;
With ethanol; sodium
With fermenting yeast
With ethanol; sodium
5-androstenedione
571-36-8

5-androstenedione

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With fermenting yeast
pregnenolone acetate
906-83-2

pregnenolone acetate

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With potassium sulfate; dipotassium peroxodisulfate; sulfuric acid; acetic acid at 25℃; Kochen des Reaktionsprodukts mit aethanol. KOH;
3β-acetoxy-5α-androstan-17-one
1239-31-2

3β-acetoxy-5α-androstan-17-one

isopropylmagnesium iodide
1068-56-0

isopropylmagnesium iodide

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With diethyl ether Versetzen mit wss. HCl und Erhitzen des Reaktionsprodukts mit methanol. KOH;
5α-androst-1-ene-3,17-dione
571-40-4

5α-androst-1-ene-3,17-dione

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With fermenting yeast
3β-acetoxy-17β-cyclohexanecarbonyloxy-5α-androstane
122747-40-4

3β-acetoxy-17β-cyclohexanecarbonyloxy-5α-androstane

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With potassium hydroxide
5α-androst-1-ene-3,17-dione
571-40-4

5α-androst-1-ene-3,17-dione

isopropyl alcohol
67-63-0

isopropyl alcohol

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With sodium
Epiandrosterone
481-29-8

Epiandrosterone

A

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

B

(3β,5α,13α)-3-hydroxyandrostane-17-one
6247-88-7

(3β,5α,13α)-3-hydroxyandrostane-17-one

C

3β-hydroxy-13,17-seco-5α-androst-13-en-17-aldehyde
138313-21-0

3β-hydroxy-13,17-seco-5α-androst-13-en-17-aldehyde

Conditions
ConditionsYield
With triethylamine In acetonitrile for 0.916667h; Product distribution; Mechanism; Ambient temperature; Irradiation; other steroides; var. solvents; var. time;
testosterone
58-22-0

testosterone

A

Epiandrosterone
481-29-8

Epiandrosterone

B

Stanolone
521-18-6

Stanolone

C

cis-androsterone
53-41-8

cis-androsterone

D

androstanedione
846-46-8

androstanedione

E

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

F

androstanediol
1852-53-5

androstanediol

Conditions
ConditionsYield
With total testicular homogenate of adult Sprague-Dawley rats treated with 6, des-Gly-NH210>LHRH ethylamide Product distribution; metabolism, <3H>labelled study, further: equine antibovine LH serum (JOAN-5-31-67);
testosterone
58-22-0

testosterone

A

Stanolone
521-18-6

Stanolone

B

cis-androsterone
53-41-8

cis-androsterone

C

androstanedione
846-46-8

androstanedione

D

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

E

androstanediol
1852-53-5

androstanediol

Conditions
ConditionsYield
With carbon dioxide; 5α-reductase in testicular cells of adult male Sprague-Dawley rats; oxygen; NADP at 37℃; for 1.5h; Product distribution; Kinetics; <3H>labelled, metabolism with or without 7α-hydroxytestosterone;
testosterone
58-22-0

testosterone

A

Stanolone
521-18-6

Stanolone

B

5β-androstan-17β-ol-3-one
571-22-2

5β-androstan-17β-ol-3-one

C

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

D

4-androstenediol
1156-92-9

4-androstenediol

E

4-Androstene-3alpha,17beta-diol
1852-61-5

4-Androstene-3alpha,17beta-diol

Conditions
ConditionsYield
With H2SiEt2; Rh-(R,R)-(+)-DIOP for 24h; Product distribution; other reducing agents;
Stanolone
521-18-6

Stanolone

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Conditions
ConditionsYield
With potassium phosphate buffer; 3β,20β-hydroxysteroid oxidoreductase from sheep fetal blood; NADPH at 37℃; for 0.5h; Product distribution; Kinetics; Km = 74 μM, Vmax = 1.3 nmol min-1 (nmol of enzyme)-1;
Multi-step reaction with 2 steps
1: 5 percent / 504 h / Rhodotorula mucilaginosa
2: 30 percent / 504 h / Rhodotorula mucilaginosa
View Scheme
With potassium phosphate; recombinant human aldo-keto reductase 1C1; NADPH In methanol at 37℃; pH=7; Kinetics; Reagent/catalyst; Concentration; aq. phosphate buffer; Enzymatic reaction; stereoselective reaction;
With aldo-keto reductase 1D1 E120H mutant; NADPH In acetonitrile at 37℃; pH=6; Kinetics; aq. phosphate buffer; Enzymatic reaction;
With potassium phosphate; rabbit aldose reductase-like protein AKR1B19; NADP In methanol at 37℃; pH=7.4; Kinetics; Enzymatic reaction;
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

acetic anhydride
108-24-7

acetic anhydride

3β,17β-diacetoxy-5α-androstane
5424-40-8

3β,17β-diacetoxy-5α-androstane

Conditions
ConditionsYield
With toluene-4-sulfonic acid for 0.0111667h; microwave irradiation;100%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

androstanedione
846-46-8

androstanedione

Conditions
ConditionsYield
With sodium hypochlorite In acetic acid at 15 - 25℃;96%
at 25℃; for 25h; electrolysis: nickel net anode, cylindrical stainless steel cathode; electrolyte: 0.01M KOH/t-butanol - water (1:1);80%
In acetone at 20℃; for 48h; UV-irradiation; Inert atmosphere;44%
With tert-butyl alcohol; N-bromoacetamide
With chromium(VI) oxide; acetic acid
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

5α-androstane-3β,17β-diol di-p-toluenesulfonate

5α-androstane-3β,17β-diol di-p-toluenesulfonate

Conditions
ConditionsYield
With pyridine at 28℃; for 48h;87%
(Z)-9-octadecenoyl chloride
112-77-6

(Z)-9-octadecenoyl chloride

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

5α-androstane-3β,17β-diol dioleate
1239669-31-8

5α-androstane-3β,17β-diol dioleate

Conditions
ConditionsYield
With dmap; 1-butyl-3-methylimidazolium chloride In pyridine at 40℃; for 0.0166667h; Microwave irradiation; Ionic liquid;85%
2,2,2-trifluoroethylbutyrate
371-27-7

2,2,2-trifluoroethylbutyrate

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

Butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester
113999-46-5

Butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
In acetone at 45℃; for 23h; with Chromobacterium viscosum lipase;83%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

1-(p-dimethylaminobenzoyl)-1,2,4-triazole
162465-84-1

1-(p-dimethylaminobenzoyl)-1,2,4-triazole

5α-androstane-3β,17β-diol bis(p-dimethylaminobenzoate)

5α-androstane-3β,17β-diol bis(p-dimethylaminobenzoate)

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane for 24h; Ambient temperature;77%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

ethyl chlorocarbonylacetate
36239-09-5

ethyl chlorocarbonylacetate

3β,17β-diethylmalonate-5α-androstane

3β,17β-diethylmalonate-5α-androstane

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃; Inert atmosphere;75%
linoleyl chloride
7459-33-8

linoleyl chloride

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

5α-androstane-3β,17β-diol dilinoleate
1239669-32-9

5α-androstane-3β,17β-diol dilinoleate

Conditions
ConditionsYield
With dmap; 1-butyl-3-methylimidazolium chloride In pyridine at 40℃; for 0.0166667h; Microwave irradiation; Ionic liquid;74%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

trifluoroethyl levulinate

trifluoroethyl levulinate

5α-androstane-3β,17β-diol-3-levulinate

5α-androstane-3β,17β-diol-3-levulinate

Conditions
ConditionsYield
With Candida antarctica lipase B In tetrahydrofuran at 45℃; for 60h;71%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

3-((1R,4aS,4bS,7S,8aS,10aS)-7-hydroxy-2,4b-dimethyltetradecahydrophenanthren-1-yl)propanal

3-((1R,4aS,4bS,7S,8aS,10aS)-7-hydroxy-2,4b-dimethyltetradecahydrophenanthren-1-yl)propanal

Conditions
ConditionsYield
With tetrabutylphosphonium dimethyl phosphate; 2,4,6-Triisopropylthiophenol; [Ir(2-(2,4-difluorophenyl)-4-(trifluoromethyl)pyridine)2(5,5'-bis(trifluoromethyl)-2,2'-bipyridine)]PF6 In toluene at 20℃; for 24h; Glovebox; Sealed tube; Irradiation;69%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

3-(4-tert-butylphenyl)glutaric anhydride
185049-55-2

3-(4-tert-butylphenyl)glutaric anhydride

3-(4-tert-Butyl-phenyl)-pentanedioic acid mono-{(3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-carboxy-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl} ester

3-(4-tert-Butyl-phenyl)-pentanedioic acid mono-{(3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-carboxy-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl} ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene Heating;67%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

5,10,15-triphenyl-20-p-benzoic acid porphyrin

5,10,15-triphenyl-20-p-benzoic acid porphyrin

5α-androstane-3β,17β-diol bis(p-(10',15',20'-triphenyl-5'-porphyrinyl)benzoate)

5α-androstane-3β,17β-diol bis(p-(10',15',20'-triphenyl-5'-porphyrinyl)benzoate)

Conditions
ConditionsYield
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane for 12h; Ambient temperature;64%
2,2,2-trifluoroethylbutyrate
371-27-7

2,2,2-trifluoroethylbutyrate

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

butyric acid-(3β-hydroxy-5α-androstanyl-(17β)-ester)
113999-47-6

butyric acid-(3β-hydroxy-5α-androstanyl-(17β)-ester)

Conditions
ConditionsYield
In acetone at 45℃; for 168h; with Bacillus subtilis protease;60%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

A

Epiandrosterone
481-29-8

Epiandrosterone

B

androstanedione
846-46-8

androstanedione

Conditions
ConditionsYield
With potato dextrose broth medium In ethanol at 24 - 26℃; for 96h; Penicillium decumbens ATCC 10436;A 60%
B 10%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate
149707-76-6

O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate

C87H84O20

C87H84O20

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 3h;36%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

A

Epiandrosterone
481-29-8

Epiandrosterone

B

Stanolone
521-18-6

Stanolone

C

androstanedione
846-46-8

androstanedione

Conditions
ConditionsYield
at 25℃; for 12h; electrolysis: nickel net anode, cylindrical stainless steel cathode; electrolyte: 0.01M KOH/t-butanol - water (1:1);A 3%
B 28%
C 30%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl trichloroacetimidate
183901-63-5

2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl trichloroacetimidate

C87H84O20

C87H84O20

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 3h;15%
5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

5alpha-Androstane-3beta,11beta,17beta-triol
32212-65-0

5alpha-Androstane-3beta,11beta,17beta-triol

Conditions
ConditionsYield
With Aspergillus tamarii KITA (QM 1223) In N,N-dimethyl-formamide at 30℃; for 120h; Microbiological reaction;1%
pyridine
110-86-1

pyridine

5-androgen-3,17-diol
571-20-0

5-androgen-3,17-diol

acetyl chloride
75-36-5

acetyl chloride

5α-androstane-3-β,17β-diol 17-acetate
10437-36-2

5α-androstane-3-β,17β-diol 17-acetate

571-20-0Relevant articles and documents

One-Step Chemo-, Regio- and Stereoselective Reduction of Ketosteroids to Hydroxysteroids over Zr-Containing MOF-808 Metal-Organic Frameworks

Llabrés i Xamena, F. X.,Mautschke, H.-H.

, p. 10766 - 10775 (2021/06/15)

Zr-containing MOF-808 is a very promising heterogeneous catalyst for the selective reduction of ketosteroids to the corresponding hydroxysteroids through a Meerwein-Ponndorf-Verley (MPV) reaction. Interestingly, the process leads to the diastereoselective synthesis of elusive 17α-hydroxy derivatives in one step, whereas most chemical and biological transformations produce the 17β-OH compounds, or they require several additional steps to convert 17β-OH into 17α-OH by inverting the configuration of the 17 center. Moreover, MOF-808 is found to be stable and reusable; it is also chemoselective (only keto groups are reduced, even in the presence of other reducible groups such as C=C bonds) and regioselective (in 3,17-diketosteroids only the keto group in position 17 is reduced, while the 3-keto group remains almost intact). The kinetic rate constant and thermodynamic parameters of estrone reduction to estradiol have been obtained by a detailed temperature-dependent kinetic analysis. The results evidence a major contribution of the entropic term, thus suggesting that the diastereoselectivity of the process is controlled by the confinement of the reaction inside the MOF cavities, where the Zr4+ active sites are located.

Formation of 5α-dihydrotestosterone from 5α-androstane-3α,17β-diol in prostate cancer LAPC-4 cells – Identifying inhibitors of non-classical pathways producing the most potent androgen

Boutin, Sophie,Roy, Jenny,Maltais, René,Poirier, Donald

supporting information, (2019/11/26)

5α-Dihydrotestosterone (5α-DHT) possesses a great affinity for the androgen receptor (AR), and its binding to AR promotes the proliferation of prostate cancer (PC) cells in androgen-dependent PC. Primarily synthesized from testosterone (T) in testis, 5α-DHT could also be produced from 5α-androstane-3α,17β-diol (3α-diol), an almost inactive androgen, following non-classical pathways. We reported the chemical synthesis of non-commercially available [4-14C]-3α-diol from [4-14C]-T, and the development of a biological assay to identify inhibitors of the 5α-DHT formation from radiolabeled 3α-diol in LAPC-4 cell PC model. We measured the inhibitory potency of 5α-androstane derivatives against the formation of 5α-DHT, and inhibition curves were obtained for the most potent compounds (IC50 = 1.2–14.1 μM). The most potent inhibitor 25 (IC50 = 1.2 μM) possesses a 4-(4-CF3-3-CH3O-benzyl)piperazinyl methyl side chain at C3β and 17β-OH/17α-C[tbnd]CH functionalities at C17 of a 5α-androstane core.

Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator Formestane

Wan, Runlan,Kong, Xi,Yang, Youzhe,Tao, Siwen,Chen, Youyou,Teichmann, Alexander Tobias,Wieland, Frank Heinrich

, (2019/12/23)

The clinical use of the steroidal aromatase inhibitor Formestane (4-hydroxandrostenedione, 4-OHA) in the treatment of advanced ER+ breast cancer has been discontinued, and therefore, interest in this remarkable drug has vanished. As a C-19 sterol, 4-OHA can undergo extensive intracellular metabolism depending on the expression of specific enzymes in the corresponding cells. We used the metabolites 4β-hydroxyandrosterone, 4β-hydroxyepiandrosterone and its 17β-reduced derivative as standards for the proof of catalytic activity present in the cell culture medium and expressed by the isolated enzymes. All of the aldo-keto reductases AKR1C1, AKR1C2, AKR1C3 and AKR1C4 catalysed the reduction of the 3-keto-group and the Δ4,5 double bond of 4-OHA at the same time. Molecular docking experiments using microscale thermophoresis and the examination of the kinetic behaviour of the isolated enzymes with the substrate 4-OHA proved that AKR1C3 had the highest affinity for the substrate, whereas AKR1C1 was the most efficient enzyme. Both enzymes (AKR1C1and AKR1C3) are highly expressed in adipose tissue and lungs, exhibiting 3β-HSD activity. The possibility that 4-OHA generates biologically active derivatives such as the androgen 4-hydroxytestosterone or some 17β-hydroxy derivatives of the 5α-reduced metabolites may reawaken interest in Formestane, provided that a suitable method of administration can be developed, avoiding oral or intramuscular depot-injection administration.

A Redox Strategy for Light-Driven, Out-of-Equilibrium Isomerizations and Application to Catalytic C-C Bond Cleavage Reactions

Ota, Eisuke,Wang, Huaiju,Frye, Nils Lennart,Knowles, Robert R.

supporting information, p. 1457 - 1462 (2019/01/25)

We report a general protocol for the light-driven isomerization of cyclic aliphatic alcohols to linear carbonyl compounds. These reactions proceed via proton-coupled electron-transfer activation of alcohol O-H bonds followed by subsequent C-C β-scission of the resulting alkoxy radical intermediates. In many cases, these redox-neutral isomerizations proceed in opposition to a significant energetic gradient, yielding products that are less thermodynamically stable than the starting materials. A mechanism is presented to rationalize this out-of-equilibrium behavior that may serve as a model for the design of other contrathermodynamic transformations driven by excited-state redox events.

Synthesis of steroid bisglucuronide and sulfate glucuronide reference materials: Unearthing neglected treasures of steroid metabolism

Pranata, Andy,Fitzgerald, Christopher C.,Khymenets, Olha,Westley, Erin,Anderson, Natasha J.,Ma, Paul,Pozo, Oscar J.,McLeod, Malcolm D.

supporting information, p. 25 - 40 (2019/01/04)

Doubly or bisconjugated steroid metabolites have long been known as minor components of the steroid profile that have traditionally been studied by laborious and indirect fractionation, hydrolysis and gas chromatography-mass spectrometry (GC–MS) analysis. Recently, the synthesis and characterisation of steroid bis(sulfate) (aka disulfate or bis-sulfate) reference materials enabled the liquid chromatography-tandem mass spectrometry (LC–MS/MS) study of this metabolite class and the development of a constant ion loss (CIL) scan method for the direct and untargeted detection of steroid bis(sulfate) metabolites. Methods for the direct LC–MS/MS detection of other bisconjugated steroids, such as steroid bisglucuronide and mixed steroid sulfate glucuronide metabolites, have great potential to reveal a more complete picture of the steroid profile. However, access to steroid bisglucuronide or sulfate glucuronide reference materials necessary for LC–MS/MS method development, metabolite identification or quantification is severely limited. In this work, ten steroid bisglucuronide and ten steroid sulfate glucuronide reference materials were synthesised through an ordered combination of chemical sulfation and/or enzymatic glucuronylation reactions. All compounds were purified and characterised using NMR and MS methods. Chemistry for the preparation of stable isotope labelled steroid {13C6}-glucuronide internal standards has also been developed and applied to the preparation of two selectively mono-labelled steroid bisglucuronide reference materials used to characterise more completely MS fragmentation pathways. The electrospray ionisation and fragmentation of the bisconjugated steroid reference materials has been studied. Preliminary targeted ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) analysis of the reference materials prepared revealed the presence of three steroid sulfate glucuronides as endogenous human urinary metabolites.

Steroid–Fullerene Hybrids from Epiandrosterone: Synthesis, Characterization and Theoretical Study

Almagro, Luis,Hernández-Castillo, David,Ortiz, Orlando,Alonso, Dayana,Ruiz, Alberto,Coro, Julieta,Herranz, María ángeles,Molero, Dolores,Martínez-álvarez, Roberto,Suárez, Margarita,Martín, Nazario

, p. 4512 - 4522 (2018/09/13)

New hybrid fullerene–steroid derivatives were prepared by using the Bingel–Hirsch protocol, by treatment of [60]fullerene with malonates bearing the appropriate steroid moieties obtained, in turn, from the functionalization of epiandrosterone, an important naturally occurring steroid hormone. Monocycloadduct C60-steroid conjugates were obtained by functionalization of ring A or ring D of the steroid moiety. We have also described the multistep preparation of a [60]fullerene hybrid dumbbell endowed with two fullerene units connected through an epiandrosterone molecule by a cyclopropanation reaction. The new compounds have been spectroscopically characterized and their redox potentials, determined by cyclic voltammetry, reveal three reversible reduction waves for monocycloadducts (8, 9 and 11, 12), whereas dumbbell-type derivative 10 exhibits the best electron-accepting abilities of the Bingel-type fullerene–steroid series. Theoretical calculations at semiempirical (AM1) and single point B3LYP-D3/6-31G+(d,p) levels have predicted the most stable conformations for the hybrid compounds and allow explaining the observed regioselectivity in the cyclopropanation reaction with dimalonate 7 during the synthesis of the dumbbell derivative.

Boosting the Catalytic Performance of Metal–Organic Frameworks for Steroid Transformations by Confinement within a Mesoporous Scaffold

Cirujano, Francisco G.,Luz, Ignacio,Soukri, Mustapha,Van Goethem, Cedric,Vankelecom, Ivo F. J.,Lail, Marty,De Vos, Dirk E.

supporting information, p. 13302 - 13306 (2017/10/17)

Solid-state crystallization achieves selective confinement of metal–organic framework (MOF) nanocrystals within mesoporous materials, thereby rendering active sites more accessible compared to the bulk-MOF and enhancing the chemical and mechanical stability of MOF nanocrystals. (Zr)UiO-66(NH2)/SiO2 hybrid materials were tested as efficient and reusable heterogeneous catalysts for the synthesis of steroid derivatives, outperforming the bulk (Zr)UiO-66(NH2) MOF. A clear correlation between the catalytic activity of the dispersed Zr sites present in the confined MOF, and the loading of the mesoporous SiO2, is demonstrated for steroid transformations.

Rapid probing of the reactivity of P450 monooxygenases from the CYP116B subfamily using a substrate-based method

Li, Ren-Jie,Xu, Jian-He,Yin, Yue-Cai,Wirth, Nicolas,Ren, Jiang-Meng,Zeng, Bu-Bing,Yu, Hui-Lei

supporting information, p. 8928 - 8934 (2016/10/13)

Developing a detailed understanding of the reactivity of self-sufficient Type IV P450 monooxygenases, four types of O-methylated substrates were designed as probes, including monoterpenes, cycloalkanes, aromatic compounds and steroids, and the efficiency of their oxyfunction was determined using a colorimetric assay which was based on the reaction between the enzymatic demethylation product, formaldehyde, and Purpald dye. The activity-based fingerprints of new P450RpMO, P450ArMO and P450CtMO (CYP116B members) indicated that CYP116B P450s preferentially oxidize substrates with aromatic components. Moreover, the hydroxylated products were detected based on the preference results. This rapid and efficient strategy, when coupled with GCMS, enables the exploration of the reactivity of other CYP116B members.

Allylic oxidation of steroidal olefins by vanadyl acetylacetonate and tert-butyl hydroperoxide

Grainger, Wendell S.,Parish, Edward J.

, p. 103 - 109 (2015/06/30)

Abstract Readily available vanadyl acetylacetonate was found to oxidize the allylic sites of Δ5 steroidal alcohols without protection of hydroxyl groups. Cholesterol, dehydroepiandrosterone, cholesterol benzoate, cholesterol acetate, pregnenolone, and 5-pregnen-3,20-diene were oxidized to 7-keto products using vanadyl acetylacetonate in one pot reactions at room temperature in the presence of oxygen and water.

Substrate specificity and inhibitor sensitivity of rabbit 20α-hydroxysteroid dehydrogenase

Endo, Satoshi,Arai, Yuki,Hara, Akira,Kitade, Yukio,Bunai, Yasuo,El-Kabbani, Ossama,Matsunaga, Toshiyuki

, p. 1514 - 1518 (2013/10/08)

In this study, we examined the substrate specificity and inhibitor sensitivity of rabbit 20α-hydroxysteroid dehydrogenase (AKR1C5), which plays a role in the termination of pregnancy by progesterone inactivation. AKR1C5 moderately reduced the 3-keto group of only 5α-dihydrosteroids with 17β- or 20α/β-hydroxy group among 3-ketosteroids. In contrast, the enzyme reversibly and efficiently catalyzed the reduction of various 17- and 20-ketosteroids, including estrogen precursors (dehydroepiandrosterone, estrone and 5α-androstan-3β- ol-17-one) and tocolytic 5β-pregnane-3,20- dione. In addition to the progesterone inactivation, the formation of estrogens and metabolism of the tocolytic steroid by AKR1C5 may be related to its role in rabbit parturition. AKR1C5 also reduced various non-steroidal carbonyl compounds, including isatin, an antagonist of the C-type natriuretic peptide receptor, and 4-oxo-2-nonenal, suggesting its roles in controlling the bioactive isatin and detoxification of cytotoxic aldehydes. AKR1C5 was potently and competitively inhibited by flavonoids such as kaempferol and quercetin, suggesting that its activity is affected by ingested flavonoids.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 571-20-0